Department of Clinical Neurosciences, Foothills Medical Centre, Calgary, Alberta, Canada.
Division of Physical Medicine & Rehabilitation, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Arch Phys Med Rehabil. 2020 Jan;101(1):113-120. doi: 10.1016/j.apmr.2019.09.005. Epub 2019 Sep 27.
To assess safety and feasibility for persons with acute spinal cord injury (SCI) using the robotic exoskeleton.
Case series observational study.
A level-1 trauma center in Canada with both acute and tertiary inpatient SCI rehabilitation units.
Eight male and 3 female (N=11) participants were recruited with a mean age of 41 years and with neurologic level of injury (C6-L2) and severity (American Spinal Injury Association Impairment Scale [AIS] A-D). The time since injury is a range of 3-15 weeks at the onset of training.
Up to 25 one-hour sessions of exoskeletal-assisted walking gait training, with participants less than 6 months from initial SCI.
Cardiopulmonary outcomes including blood pressure, heart rate, and peripheral oxygen saturation; and perceived physical exertion using the Borg CR10 Scale were recorded. Gait parameters were measured by 6-minute walk test (6MWT) and 10-meter walk test (10MWT). Up Time, walk time, and number of steps were detailed longitudinally. Safety was assessed with regard to pain, falls, and skin integrity.
No serious adverse events occurred. Blood pressure decreased following initial sit to stand and increased during walking. Symptoms of hypotension were rare and improved with increased number of sessions. Perceived exertion was reported on average to be moderate (mean of 3.1). There was no significant increase in pain scores by Visual Analog Scale. On 6MWT, participants covered more distance (mean [m] ± SD, 117.1±11.7) in session 25 compared to session 2 (mean [m] ± SD, 47.6±6.6). On the 10MWT, all participants showed consistently improved gait speed; with participants traveling an average of 3.2 times faster during their last training session (mean [m/s] ± SD, 0.40±0.04) in comparison to session 2 (mean [m/s] ± SD, 0.12±0.01).
Exoskeletal-assisted walking in acute rehabilitation (<6mo) following SCI appears to be both safe and feasible.
评估急性脊髓损伤(SCI)患者使用机器人外骨骼的安全性和可行性。
病例系列观察性研究。
加拿大 1 级创伤中心,设有急性和三级住院 SCI 康复病房。
招募了 8 名男性和 3 名女性(共 11 名)参与者,平均年龄为 41 岁,损伤神经平面(C6-L2)和损伤严重程度(美国脊髓损伤协会损伤分级 [AIS] A-D)。从损伤开始到训练开始的时间范围为 3-15 周。
进行多达 25 次外骨骼辅助行走步态训练,参与者距离初次 SCI 时间不到 6 个月。
心肺功能结果,包括血压、心率和外周血氧饱和度;使用 Borg CR10 量表记录感知的体力消耗。步态参数通过 6 分钟步行测试(6MWT)和 10 米步行测试(10MWT)进行测量。详细记录了站立时间、行走时间和步数的纵向变化。安全性评估包括疼痛、跌倒和皮肤完整性。
未发生严重不良事件。初始坐站起后血压下降,行走时血压升高。低血压症状少见,随着训练次数的增加而改善。平均而言,感知用力程度为中度(平均 3.1)。视觉模拟评分的疼痛评分无显著增加。在 6MWT 中,参与者在第 25 次训练中比第 2 次训练(平均[米]±SD,47.6±6.6)多走了 117.1±11.7 米。在 10MWT 中,所有参与者的行走速度均持续提高;在最后一次训练中,参与者的平均行走速度提高了 3.2 倍(平均[米/秒]±SD,0.40±0.04),而在第 2 次训练中(平均[米/秒]±SD,0.12±0.01)。
急性康复(<6 个月)期间使用外骨骼辅助行走对 SCI 患者似乎是安全且可行的。